Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06786858 · ClinicalTrials.gov registry record · NA

Hand Exoskeleton Training Study

A NA study of Stroke, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06786858 is a NA study of Stroke that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 15 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06786858, a NA study of Stroke, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the HandMATE device's effectiveness in the rehabilitation of stroke patients and asses if the HandMATE application is received well by stroke survivors. Participants will use the HandMate device in clinic and in the home. They will also complete clinical upper extremity assessments.

Conditions Studied

Interventions

  • DEVICE HandMate

Study Locations (1)

District of Columbia

  • MedStar National Rehabilitation Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-01-04
Est. Completion 2025-01-31
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT06786858

The ClinicalTrials.gov registry entry for NCT06786858 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which HandMate is the first listed.

NCT06786858 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06786858 about?

NCT06786858 is a clinical study titled "Hand Exoskeleton Training Study". The goal of this study is to evaluate the HandMATE device's effectiveness in the rehabilitation of stroke patients and asses if the HandMATE application is received well by stroke survivors. Participants will use the HandMate device in clinic and in the home. They will also complete clinical upper ...

What is the current status of trial NCT06786858?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-01-04. Estimated completion is 2025-01-31.

What conditions does trial NCT06786858 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06786858?

The interventions under investigation include: HandMate (DEVICE).

Who is sponsoring clinical trial NCT06786858?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06786858 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.